Polymeric micelle nanocarriers for the cutaneous delivery of tacrolimus: a targeted approach for the treatment of psoriasis.

• Results Overview

  A new way of delivering tacrolimus using tiny carriers called polymeric micelles was more effective at getting the medication into the skin compared to the existing ointment (Protopic), particularly targeting the areas affected by psoriasis without increasing absorption into the bloodstream.

• Study Summary

  Num Participants:

  None

  Study Type:

  Observational

  Control Group:

  0.1% Tacrolimus Ointment (Protopic)

  Efficacy End Points Treatment:

  {'Skin deposition': 1.5}

  Efficacy End Points Control:

  {'Skin deposition': 0.47}

  Side Effects Treatment:

  Adverse Event	Severity	Percentage Affected

  Side Effects Control:

  Adverse Event	Severity	Percentage Affected